Under the terms of the deal, Bnoon will bring its global expertise in fertility and women’s-health care and partner with Almoosa Health’s strong regional infrastructure and brand in the Kingdom. The newly co-branded facility at Almoosa Specialist Hospital is intended to enhance access for local families, with insiders indicating plans to more than double IVF cycles in the region.
The move aligns with the Kingdom’s ambition to strengthen private-sector healthcare and diversify service delivery under the Saudi Vision 2030 framework. Fertility services form part of a wider push to shift from basic treatments towards specialised care, including genetic diagnostics, egg-freezing and male-infertility services. Bnoon states it currently performs over 5,000 IVF cycles annually, hosts more than 70 clinicians and offers inclusive fertility-preservation programmes.
Commenting at the exhibition were Majd Abu Zant, Chief Executive Officer & Managing Director of Global Fertility, and Dr Malek Almoosa, Chief Executive Officer of Almoosa Health. They emphasised that the partnership would deliver a one-stop fertility ecosystem built for the Eastern Province’s population and for medical-tourism opportunity from neighbouring Gulf states. Abu Zant said the collaboration “redefines how fertility care is delivered, making it more personal, more human and built entirely around you.”
Almoosa Specialist Hospital, founded in 1996 in Al-Ahsa as the first private hospital there, reported over 26,500 patients from various regions of the Kingdom and more than 7,300 from outside Saudi Arabia in a recent two-year span. Its parent group, Almoosa Health, disclosed revenues of SAR 979 million and net income of SAR 98 million for 2023, with bed capacity expanding across the Eastern Province.
The strategic logic is clear: by pairing Bnoon’s specialised fertility service offerings with Almoosa Health’s regional footprint, the partners aim to capture growing demand for assisted-reproduction services in the Gulf region, where demographic shifts and delayed childbearing are driving interest. Clinics within Bnoon also emphasise a holistic model of care spanning diagnostics, IVF, egg- and sperm-freezing, and support through pregnancy.
At the administrative level the partnership signals an intensification of private-sector engagement in Saudi healthcare. The Ministry of Health has encouraged such collaborations to ease pressure on public hospitals and drive growth in non-communicable-disease services and specialised care. In its 2023 prospectus, Almoosa Health identified a gap of some 2,500 to 3,000 beds in its region by 2030 and emphasised planned expansion of primary-care centres alongside its acute-care offering.
However, the venture poses execution challenges. Integrating high-complexity fertility services into a regional hospital platform requires stringent quality control, recruitment of embryologists and specialists, and maintaining international success-rate benchmarks. While Bnoon reports a success rate of over 60 per cent for women under 35, replicating such outcomes across new jurisdictions will depend on patient-case mix, lab standards and referral networks.
From a market-perspective the investment offers upside but also risk. The Gulf fertility-services market is competitive, with global chains and local operators vying for share. Pricing, insurance-coverage models and cross-border patient flows will be key determinants of the initiative’s viability. The partners will need to balance providing accessible service volumes while preserving margins and outcomes to sustain profitability.
Topics
Saudi Arabia